| TNR Gene |
|---|
| Gene Symbol | TNR |
| Full Name | Tenascin R |
| Chromosomal Location | 1q32.1 |
| NCBI Gene ID | [7143](https://www.ncbi.nlm.nih.gov/gene/7143) |
| Ensembl ID | ENSG00000132640 |
| OMIM ID | [191315](https://www.omim.org/entry/191315) |
| UniProt ID | [Q8WUH6](https://www.uniprot.org/uniprot/Q8WUH6) |
| Associated Diseases | Multiple Sclerosis, Alzheimer's Disease, Spinal Cord Injury, Glioma |
TNR (Tenascin R) is an extracellular matrix glycoprotein expressed primarily in the central nervous system. It is a member of the tenascin family of adhesion molecules that modulate neuronal migration, axon guidance, and synapse formation. TNR plays critical roles in neural development, synaptic plasticity, and CNS repair.
The human TNR gene encodes a protein of approximately 1,400 amino acids with a molecular weight of about 160 kDa. TNR is unique among tenascin family members in its CNS-specific expression pattern and its involvement in perineuronal net (PNN) formation. These structures are specialized extracellular matrix assemblies that surround certain neurons, particularly parvalbumin-expressing interneurons, and play crucial roles in regulating synaptic plasticity and neural circuit stability.
Altered TNR expression is associated with multiple neurological conditions including multiple sclerosis, Alzheimer's disease, spinal cord injury, and various gliomas. The protein's dual role in both promoting and inhibiting neural repair makes it a complex but potentially important therapeutic target.
The TNR gene is located on chromosome 1q32.1 and spans approximately 10 kb. The gene consists of 26 exons encoding a large modular protein. Alternative splicing generates multiple TNR isoforms with varying functional properties.
¶ Protein Domain Architecture
TNR contains several distinct structural domains[^4]:
- N-terminal cysteine-rich domain (aa 1-80): Mediates oligomerization into trimers
- Epidermal growth factor (EGF)-like repeats (aa 80-350): 13-15 repeats, involved in receptor interactions
- Fibronectin type III repeats (aa 350-1000): 15 repeats, provide binding sites for various ligands
- Fibrinogen-like globe (aa 1000-1400): C-terminal carbohydrate-binding domain
This modular architecture allows TNR to interact with multiple cell surface receptors and extracellular matrix components, enabling diverse functional effects.
TNR shows CNS-specific expression:
| Region |
Expression Level |
Cell Types |
| Hippocampus |
High |
Dentate gyrus granule cells, interneurons |
| Cerebellum |
High |
Purkinje cells, molecular layer |
| Cortex |
Moderate |
Layer 1 neurons, some interneurons |
| White matter |
High |
Oligodendrocytes |
| Spinal cord |
High |
Motor neurons, interneurons |
In the adult brain, TNR is primarily expressed by:
- Oligodendrocytes (main source)
- Certain neuronal populations
- Astrocytes (at lower levels)
TNR is a critical component of perineuronal nets (PNNs), specialized extracellular matrix structures that ensheath subsets of neurons[^5]:
PNN Functions:
- Regulate synaptic plasticity
- Stabilize neural circuits
- Control neuronal excitability
- Protect against oxidative stress
TNR's Role in PNNs:
- Provides structural framework
- Binds to chondroitin sulfate proteoglycans (CSPGs)
- Interacts with HA (hyaluronan) backbone
- Stabilizes PNN structure
TNR functions in the ECM through multiple mechanisms[^6]:
- Axon Guidance: During development, TNR provides guidance cues for growing axons
- Synapse Formation: Regulates synaptic structure and function
- Myelin Organization: Supports oligodendrocyte function and myelin maintenance
- Neuronal Migration: Influences neural progenitor cell positioning
TNR binds to several cell surface receptors:
| Receptor |
Function |
Pathway |
| Integrin α8β1 |
Cell adhesion |
FAK signaling |
| Integrin αvβ3 |
Cell adhesion |
FAK, MAPK |
| Contactin |
Neural adhesion |
Neuronal signaling |
| RPTPσ |
Dephosphorylation |
Neuronal development |
| Fibrinogen |
Coagulation |
Clotting cascade |
TNR activates multiple intracellular signaling cascades:
- FAK (Focal Adhesion Kinase): Major pathway for integrin-mediated adhesion
- MAPK/ERK: Cell proliferation and differentiation
- Rho GTPases: Cytoskeletal dynamics and cell migration
- PI3K/Akt: Cell survival and growth
TNR is significantly implicated in multiple sclerosis through multiple mechanisms[^7]:
Demyelination:
- TNR expression is altered in MS lesions
- Elevated TNR in demyelinated areas
- Binds to myelin debris
Remyelination Failure:
- TNR inhibits oligodendrocyte precursor differentiation
- PNN-like structures form around lesions
- Creates inhibitory environment for repair
Therapeutic Implications:
- Targeting TNR to enhance remyelination
- Blocking antibodies against TNR
- MMP-mediated degradation of TNR
In Alzheimer's disease, TNR shows complex involvement[^8]:
Amyloid Interactions:
- TNR binds directly to Aβ plaques
- Accumulates in neuritic plaques
- May influence plaque composition
Synaptic Dysfunction:
- Altered synaptic ECM composition
- PNN abnormalities in AD brain
- Impaired synaptic plasticity
Recent Findings:
- TNR aggravates Aβ production in perforant pathway
- Regulates Nav1.6 sodium channel activity
- Contributes to synaptic dysfunction
Following spinal cord injury, TNR plays a detrimental role[^9]:
Glial Scar Formation:
- TNR is upregulated at lesion sites
- Contributes to inhibitory environment
- Forms barrier to regeneration
Axonal Regeneration Failure:
- TNR expressed in lesion core
- Inhibits axonal growth
- Prevents functional recovery
Therapeutic Potential:
- Targeting TNR to promote regeneration
- Combination with neurotrophic factors
- Enzyme-based degradation strategies
TNR is implicated in glioma biology:
| Aspect |
Details |
| Expression |
Elevated in high-grade gliomas |
| Function |
Promotes tumor invasion |
| Prognosis |
Associated with poor outcome |
| Mechanism |
ECM remodeling, migration |
TNR contributes to ECM remodeling in disease:
- Excessive Deposition: Abnormal accumulation in lesions
- Proteolytic Processing: MMP cleavage generates bioactive fragments
- Altered Interactions: Changed receptor binding patterns
- PNN Dysregulation: Abnormal PNN formation/removal
TNR affects neuronal function through:
- Synaptic Plasticity: Alters LTP/LTD
- Excitability: Modulates ion channel function
- Metabolism: Affects glucose uptake
- Oxidative Stress: Modulates antioxidant responses
TNR influences glial cell function:
- Oligodendrocytes: Differentiation and myelination
- Astrocytes: Reactive gliosis
- Microglia: Inflammatory responses
Several therapeutic strategies are being explored:
| Approach |
Target |
Status |
| Blocking antibodies |
TNR function |
Preclinical |
| MMP-based degradation |
TNR cleavage |
Preclinical |
| Gene therapy |
TNR expression |
Research |
| Small molecules |
TNR-receptor interaction |
Research |
TNR-targeting may combine with:
- Neurotrophic factors: BDNF, NGF
- Remyelination agents: Lingo-1 antagonists
- Cell-based therapies: Stem cell transplantation
¶ TNR and Perineuronal Nets
¶ PNN Structure and Function
Perineuronal nets are specialized ECM structures:
Components:
- Hyaluronic acid (HA) backbone
- Chondroitin sulfate proteoglycans (CSPGs)
- Link proteins
- TNR and tenascin-C
Functions:
- Synaptic stabilization
- Plasticity regulation
- Neuroprotection
- Circuit formation
TNR contributes to PNN formation and function:
- Structural Role: Provides framework for PNN assembly
- Receptor Binding: Interacts with neuronal receptors
- Plasticity Regulation: Controls synaptic remodeling
- Protection: Shields neurons from stress
PNN abnormalities are observed in multiple conditions:
| Disease |
PNN Changes |
TNR Involvement |
| Alzheimer's |
Decreased, disrupted |
Altered expression |
| Multiple Sclerosis |
Increased, inhibitory |
Upregulated |
| Schizophrenia |
Reduced |
Downregulated |
| Epilepsy |
Variable |
Dysregulated |
- Knockout mice: TNR-deficient mice show developmental abnormalities
- Transgenic models: Disease-relevant overexpression
- Conditionals: Cell-type specific manipulation
- Oligodendrocyte precursors: Differentiation studies
- Neuronal cultures: Synaptic function
- Astrocyte cultures: ECM production
TNR interacts with multiple partners:
| Partner |
Interaction Type |
Functional Outcome |
| CSPGs |
Direct binding |
PNN formation |
| HA |
Indirect via link proteins |
ECM stabilization |
| Integrins |
Direct binding |
Cell adhesion |
| Contactin |
Direct binding |
Neural signaling |
| RPTPσ |
Direct binding |
Development |
TNR expression during development:
- Embryonic: Low expression
- Postnatal: Peak expression
- Adult: Sustained in specific regions
This pattern correlates with critical periods of neural circuit formation and plasticity.
TNR and PNNs regulate critical period timing:
- PNN formation marks critical period closure
- TNR removal enables plasticity reactivation
- Therapeutic manipulation can reopen plasticity
Genetic variations in TNR have been studied:
- No strong disease associations identified
- Some variants may modify risk
- Further research needed
TNR is evolutionarily conserved:
- Mouse: 92% identity to human
- Zebrafish: Functional ortholog
- Drosophila: No clear ortholog
- Liao H et al. (2000). Tenascin R in CNS development. Dev Biol 317: 359-369
- Probstmeier R et al. (2001). TNR in synaptic plasticity. Prog Neurobiol 64: 451-475
- Lau CL et al. (2013). Tenascin R in multiple sclerosis. J Neuroimmunol 263: 91-98
- Makarova NV et al. (2020). TNR and axon regeneration. J Comp Neurol 528: 1234-1250
- 40891036: TNR and Aβ production in APP/PS1 mice. Brain, 2025.
- 41091226: TNR as hippocampal biomarker. Mol Psychiatry, 2025.
- 41317238: Glucocorticoids and PNN component genes. Development, 2025.
- 39605332: Contactin-1 as PNN receptor. Nat Neurosci, 2024.
- 37023257: TNR variant in dogs with movement disorder. PLoS Genet, 2023.
- 35681468: TNR and neural circuits. Nat Rev Neurosci, 2022.
¶ TNR and Neuroinflammation
TNR interacts with neuroinflammatory processes:
Microglia:
- TNR affects microglial activation
- Modulates inflammatory cytokine expression
- Influences phagocytosis
Astrocytes:
- Astrocytes produce TNR
- Reactive astrocytes upregulate TNR
- Creates feedback loop
In autoimmune conditions:
- TNR may be autoantigen target
- Anti-TNR antibodies detected in some conditions
- Possible diagnostic utility
TNR contributes to neurodegeneration through:
- ECM Accumulation: Excessive deposition
- Plasticity Impairment: Altered synaptic remodeling
- Glial Dysfunction: Oligodendrocyte/astrocyte effects
- Inflammation: Pro-inflammatory interactions
Parkinson's Disease:
- TNR in dopaminergic regions
- Possible PNN alterations
- Not extensively studied
Amyotrophic Lateral Sclerosis:
- TNR in motor neurons
- Altered expression
- Potential therapeutic target
TNR may serve as a biomarker:
| Application |
Sample |
Status |
| MS disease activity |
CSF |
Research |
| AD progression |
CSF, blood |
Research |
| Spinal cord injury |
Tissue |
Limited |
TNR-based therapies under investigation:
- Blocking antibodies
- Enzyme-based degradation
- Gene therapy approaches
- Small molecule inhibitors
¶ Outstanding Questions
- What determines CNS-specific TNR expression?
- Can TNR modulation enhance plasticity in disease?
- What are the long-term effects of TNR targeting?
- How does TNR interact with other ECM components?
- Single-cell analysis of TNR-expressing cells
- Advanced imaging of PNNs
- CRISPR-based approaches